Results 231 to 240 of about 281,573 (395)

The Role of Tumor Microenvironment and Targeted Therapy in Chronic Lymphocytic Leukemia. [PDF]

Curr Issues Mol Biol
Saleh K, Arbab A, Khalife N, Khoury R, Ibrahim R, Hachem MA, Khalil C, Bou Orm C, Sawan J, Lafarge G, Masri N, Tikriti Z, Chahine C, Le Cesne A.   +13 more
europepmc   +1 more source

T cells in B cell chronic lymphocytic leukemia. II. Lack of antigen-specific T suppressor cells and their progenitors. [PDF]

, 1985
A C Bloem, C J Heijnen, Bert J. E. G. Bast, R. E. Ballieux   +3 more
openalex   +1 more source

Extracellular Vesicle‐Based mRNA Therapeutics and Vaccines

Exploration, EarlyView.
This review provides a comprehensive analysis of recent advancements in extracellular vesicle (EV)‐based messenger RNA (mRNA) applications for therapeutics and vaccines. It systematically outlines strategies for mRNA encapsulation within EVs and elucidates the challenges associated with this technology, offering insights into future research directions
Qi Li, Haonan Xing, Abid Naeem, Kaiyue Zhang, Aiping Zheng, Yuanyu Huang, Mei Lu   +6 more
wiley   +1 more source

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia [PDF]

, 1989
MJ Keating, H. Kantarjian, Moshe Talpaz, J R Redman, Charles Koller, Barthel Barlogie, William S. Velasquez, William Plunkett, EJ Freireich, KB McCredie   +9 more
openalex   +1 more source

Delving Into the Dialogue between Epigenetic Modifications and Immunometabolism in Cancer

Advanced Genetics, EarlyView.
Epigenetic modifications—including DNA, histone, and RNA modifications—and their interplay play pivotal roles in tumorigenesis and progression. The crosstalk between tumor immunometabolism and epigenetic regulation has garnered significant attention, as metabolites serve as epigenetic modulators to modulate immune cell activation, differentiation, and ...
Xiaowen Xie, Weici Liu, Pengpeng Zhang, Peng Luo, Bufu Tang, Wenjun Mao   +5 more
wiley   +1 more source

Expression of HERV-K and embryonic genes in chronic lymphocytic leukemia and their association with therapy regimens. [PDF]

Blood Adv
Matteucci C, Petrone V, Giovinazzo A, Laureana R, Postorino M, Pupo L, Cipriani C, Toschi N, Fanelli M, Minutolo A, Paterno G, Buzzatti E, Sinibaldi Vallebona P, Zucchetto A, Pozzo F, Gattei V, Del Poeta G, Venditti A, Balestrieri E, Del Principe MI.   +19 more
europepmc   +1 more source

Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Richter's syndrome: A study of 25 cases [PDF]

, 1981
Jean‐Luc Harousseau, Georges Flandrin, Guido Tricot, J C Brouet, M Séligmann, Jean Bernard   +5 more
openalex   +1 more source

Molecular Features Accompanying Richter's Transformation in Patients with Chronic Lymphocytic Leukemia. [PDF]

Int J Mol Sci
Wang X, Chen J.
europepmc   +1 more source

Chronic lymphocytic leukemia

Hematology, 2015
openaire   +3 more sources

Targeting the Menin–KMT2A interaction in leukemia: Lessons learned and future directions

International Journal of Cancer, EarlyView.
Abstract Chromosomal rearrangements involving the Mixed Lineage Leukemia gene (MLL1, KMT2A) are defining a genetically distinct subset in about 10% of human acute leukemias. Translocations involving the KMT2A‐locus at chromosome 11q23 are resulting in the formation of a chimeric oncogene, where the N‐terminal part of KMT2A is fused to a variety of ...
Florian Perner, Jayant Y. Gadrey, Scott A. Armstrong, Michael W. M. Kühn   +3 more
wiley   +1 more source